estetrol E4
Selected indexed studies
- Estetrol (E4): the new estrogenic component of combined oral contraceptives. (Expert Rev Clin Pharmacol, 2020) [PMID:32238069]
- [Estetrol (E4)]. (Nihon Rinsho, 1995) [PMID:8753305]
- Insights on estetrol, the native estrogen: from contraception to hormone replacement therapy. (Minerva Obstet Gynecol, 2024) [PMID:39283289]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Drospirenone and estetrol: evaluation of a newly approved novel oral contraceptive. (2023) pubmed
- Estetrol-drospirenone combination oral contraceptive: North American phase 3 efficacy and safety results. (2021) pubmed
- Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone. (2021) pubmed
- Estetrol (E4): the new estrogenic component of combined oral contraceptives. (2020) pubmed
- [Estetrol (E4)]. (1995) pubmed
- Insights on estetrol, the native estrogen: from contraception to hormone replacement therapy. (2024) pubmed
- Efficacy and safety of estetrol (15 mg)/drospirenone (3 mg) combination in a cyclic regimen for the treatment of primary and secondary dysmenorrhea: a multicenter, placebo-controlled, double-blind, randomized study. (2025) pubmed
- Estetrol-Drospirenone combination oral contraceptive: a clinical study of contraceptive efficacy, bleeding pattern and safety in Europe and Russia. (2022) pubmed
- The rediscovery of estetrol and its implications for estrogen treatment. (2025) pubmed
- Impact of Estetrol Combined with Drospirenone on Blood Coagulation and Fibrinolysis in Patients with Endometriosis: A Multicenter, Randomized, Open-Label, Active-Controlled, Parallel-Group Study. (2024) pubmed